Actinogen Medical (ACW) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Actinogen Medical Advances Alzheimer’s Research with Promising Xanamem TrialApril 1, 2025 | tipranks.comActinogen Advances Xanamem Development with FDA Meeting SuccessMarch 27, 2025 | tipranks.comActinogen Medical Advances Alzheimer’s and Depression Treatment with XanamemMarch 26, 2025 | tipranks.comActinogen Medical Advances Clinical Trials with Positive Meeting OutcomesMarch 13, 2025 | tipranks.comXanamem: Alzheimer's breakthrough set for 2025, 2026March 5, 2025 | msn.comActinogen Medical Initiates Employee Share Buy-BackMarch 4, 2025 | tipranks.comActinogen Medical Advances in Neurological Drug TrialsMarch 2, 2025 | tipranks.comActinogen reports busy 6 months as development of Xanamem molecule ramps upFebruary 24, 2025 | msn.comActinogen Medical Reports Reduced Losses Amid R&D FocusFebruary 23, 2025 | tipranks.comActinogen Medical Advances Alzheimer’s and Depression Treatments with Promising Trial ResultsFebruary 23, 2025 | tipranks.comActinogen Medical Calls for Shareholder Meeting Amid Promising Trial ResultsFebruary 9, 2025 | tipranks.comActinogen Medical Publishes Key Xanamem Study Supporting Ongoing TrialsFebruary 5, 2025 | tipranks.comActinogen announces new and unique nonproprietary name of 'emestedastat' for XanamemFebruary 5, 2025 | finance.yahoo.comInvestors in Actinogen Medical (ASX:ACW) have unfortunately lost 76% over the last three yearsFebruary 2, 2025 | finance.yahoo.comActinogen Medical Advances Alzheimer’s Clinical Trial and Prepares for CommercializationJanuary 28, 2025 | tipranks.comActinogen’s Lead Drug Xanamem Gains WHO Recognition Amid Ongoing TrialsJanuary 12, 2025 | tipranks.comActinogen Medical Sees Change in Major Shareholder StakeDecember 18, 2024 | tipranks.comActinogen Medical Lists 59.5 Million Shares on ASXDecember 16, 2024 | markets.businessinsider.comActinogen Medical Expands with New Securities QuotationDecember 12, 2024 | tipranks.comActinogen Medical Reveals Top Option HoldersDecember 12, 2024 | tipranks.comActinogen Medical Lists New Trading Options on ASXDecember 12, 2024 | tipranks.comActinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trialDecember 9, 2024 | finance.yahoo.comActinogen Medical Expands Alzheimer’s Drug Trial to USDecember 8, 2024 | tipranks.comemThis biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game /emNovember 24, 2024 | msn.comThis biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the gameNovember 24, 2024 | msn.comActinogen Medical’s Promising Advances in Neurological TreatmentsNovember 14, 2024 | markets.businessinsider.comActinogen receives $9M R&D tax rebate to fund Alzheimer's trialNovember 12, 2024 | msn.comActinogen Medical Secures $9 Million R&D Rebate BoostNovember 12, 2024 | markets.businessinsider.comActinogen Medical Expands Shares Amid Drug Development ProgressNovember 4, 2024 | markets.businessinsider.comActinogen Medical Expands Market Presence with New SecuritiesNovember 4, 2024 | markets.businessinsider.comActinogen Medical Advances in Neurological Drug DevelopmentNovember 3, 2024 | tipranks.comActinogen Medical Highlights Alzheimer’s Research ProgressOctober 31, 2024 | markets.businessinsider.comHealth Check: Hold the front page for a rush of clinical trial updatesOctober 30, 2024 | msn.comActinogen Medical Advances Alzheimer’s Trials and Boosts CapitalOctober 30, 2024 | markets.businessinsider.comActinogen Medical Plans New Share Issue Amid Xanamem ProgressOctober 30, 2024 | msn.comActinogen Medical Boosts Leadership with New CCOOctober 29, 2024 | markets.businessinsider.comActinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvalsSeptember 24, 2024 | msn.comActinogen Medical Limited: Actinogen announces further positive results on depression in the XanCIDD phase 2a trialAugust 27, 2024 | finanznachrichten.deActinogen Medical (ASX:ACW) shareholder returns have been enviable, earning 506% in 5 yearsAugust 27, 2024 | finance.yahoo.comASX Health Stocks: Actinogen skyrockets 125pc on antidepressant drug trial resultsAugust 26, 2024 | msn.comActinogen announces further positive results on depression in the XanCIDD phase 2a trialAugust 26, 2024 | finance.yahoo.comActinogen Medical Ltd (ACW)August 17, 2024 | investing.comWhy Actinogen, ASX, Burgundy Diamond, and Lifestyle Communities shares are sinking todayAugust 14, 2024 | msn.comASX Health Stocks: Psilocybin drug shows promise for fibromyalgia pain reliefAugust 13, 2024 | msn.comWhy is this ASX healthcare stock crashing 67% on Monday?August 12, 2024 | msn.comActinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trialAugust 12, 2024 | msn.comClosing Bell: Markets still bumpy as ASX drops again; Qantas admits board made mistakesAugust 8, 2024 | msn.comEnrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trialApril 22, 2024 | finance.yahoo.comActinogen treats first subject in Alzheimer’s disease therapy trialApril 16, 2024 | msn.comActinogen Medical Limited: First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trialApril 15, 2024 | finanznachrichten.de Get Actinogen Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ACW and its competitors with MarketBeat's FREE daily newsletter. Email Address ACW Media Mentions By Week ACW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACW News Sentiment▼0.000.49▲Average Medical News Sentiment ACW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACW Articles This Week▼00▲ACW Articles Average Week Get Actinogen Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ACW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aeva Technologies News Today Serve Robotics News Today ChargePoint News Today Holley News Today The Shyft Group News Today Hyliion News Today Niu Technologies News Today Supreme News Today Motorcar Parts of America News Today Luminar Technologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:ACW) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinogen Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinogen Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACW Stock Free ACW Stock Alerts